Guinea vs Mozambique: Previously treated cases tested for RR-/MDR-TB
Guinea
29.0%
in 2024
Mozambique
25.0%
in 2024
Guinea rank
161st
Mozambique rank
164th
Previously treated cases tested for RR-/MDR-TB over time
- Guinea
- Mozambique
How they compare
Guinea currently reports 29.0% against 25.0% in Mozambique, a difference of 4.0%.
That makes Guinea's figure about 1.2 times Mozambique's.
The two have swapped places 7 times across 19 shared years of data; in 2005 it was Mozambique ahead.
Guinea ranks 161st and Mozambique ranks 164th of 180 countries.
Across the 3 decades both report, Guinea averaged higher in 1 and Mozambique in 2.
Head to head by decade
| Decade | Guinea | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.9% | 12.8% | 7.0% | Mozambique |
| 2010s | 45.9% | 33.2% | 12.7% | Guinea |
| 2020s | 70.8% | 72.4% | 1.6% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea or Mozambique?
- Guinea, at 29.0% against 25.0% in Mozambique as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea and Mozambique?
- 4.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Mozambique?
- 19 years are reported by both, from 2005 to 2024.
- How do Guinea and Mozambique rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea ranks 161st and Mozambique ranks 164th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.